Table 2.
Comparison of prognostic markers between controls and ACS patients.
| Control | ACS | p-value (p-adj.) | p-value (p-adj.) | |||
|---|---|---|---|---|---|---|
| Total ACS | UAP | STEMI | Control vs. Total ACS | UAP vs. STEMI | ||
| n | 30 | 60 | 30 | 30 | ||
| TMAO(μM) | 2.15 ± 0.9 | 4.33 ± 2.49 | 4.31 ± 2.8 | 4.35 ± 2.19 | <0.001 (0.221) | 0.954 (0.004) |
| IL-6(pg/ml) | 20.64 ± 5.95 | 34.54 ± 79.68 | 25.95 ± 18.12 | 43.12 ± 111.52 | 0.344 (0.204) | 0.409 (0.124) |
Data are presented as mean ± SD or median (Q1, Q3) for all numerical data.
Differences between two groups were compared using two-sample t-test for numerical data with normal distribution; Mann-Whitney U test for numerical data without normal distribution; two-way ANOVA after adjusting for variables significantly different in Table 1 (with p < 0.05).
Bold values indicate statistical significance (p < 0.05).
Abbreviations: ACS, acute coronary syndrome; UAP, unstable angina pectoris; STEMI, ST-segment elevation myocardial infarction; TMAO, trimethylamine N-oxide; IL-6, interleukin-6.